Currently out of the existing stock ratings of Ben Haynor, 87 are a BUY (87%), 12 are a HOLD (12%), 1 are a SELL (1%).

Ben Haynor

Work Performance Price Targets & Ratings Chart

Analyst Ben Haynor, currently employed at LAKE STREET, carries an average stock price target met ratio of 49.02% that have a potential upside of 54.33% achieved within 208 days. Previously, Ben Haynor worked at ALLIANCE GLOBAL PARTNERS.

Ben Haynor’s has documented 196 price targets and ratings displayed on 21 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on PROF, Profound Medical Corp at 07-Jan-2026.

Wall Street Analyst Ben Haynor

Analyst best performing recommendations are on TTOO (T2 BIOSYSTMS).
The best stock recommendation documented was for SRTS (SENSUS HEALTHCARE) at 5/6/2020. The price target of $2.4 was fulfilled within 2 days with a profit of $0.2 (7.69%) receiving and performance score of 38.46.

Average potential price target upside

of $113.9 (25.33%) on DRIO (DARIOHEALTH CORP).
of $39.38 (59.9%) on MOTS (MOTUS GI HOLDINGS).
of $29.07 (30.61%) on HSKA (HESKA).

DRIO DarioHealth Corp EYEG AB Corporate Bond ETF HSKA Heska ICCM Icecure Medical IMAC Imac Holdings KIN Kindred Biosciences MYO Myomo OPGN OpGen PROF Profound Medical Corp RSLS ReShape Lifesciences TTOO T2 Biosystms PODD Insulet KPRX Kiora Pharmaceuticals MOTS Motus GI Holdings VIVE Viveve Medical SRTS Sensus Healthcare ITMR Itamar Medical Ltd NSPR InspireMD BEAT Heartbeam BIOC Biocept EKSO Ekso Bionics Holdings

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Charles Rhyee (TD COWEN)